Skip to main content
Fig. 7 | Egyptian Journal of Radiology and Nuclear Medicine

Fig. 7

From: Role of interim positron emission tomography/computed tomography in assessment of lymphoma treatment response

Fig. 7

Male patient, 48 years old, diagnosed of HD (mixed cellularity) received different lines of chemotherapy then underwent autologous bone marrow transplant followed by radiotherapy, after 10 years; he developed weight loss and elevated serum LDH. His international prognostic risk category was high-intermediate risk. First post-transplant PET/CT (hepatic reference 1.7) axial CT (A & C) and axial fused PET/CT (B & D) images show metabolically active subcarinal LN (white arrows) measuring about 3.2 × 1.9 cm and achieving SUVmax 3 & metabolically active bilateral inguinal LNs (yellow arrows), the largest measuring about 9 mmm in short axis and achieving SUVmax 8.4. FNAC from right external iliac LNs was done confirming the relapse. The patient received 3 cycles chemotherapy. Second post-transplant PET/CT (hepatic reference 2.7) axial CT (A & C) and axial fused PET/CT (B & D) images show morphological and metabolic stationary course of the subcarinal (white arrows) and bilateral inguinal (yellow arrows) LNs. It was reported as stable disease with Deauville score 4

Back to article page